Study Efficacy and Safety in Comparative Use of Investigational Product Adjuvant Treatment in Onychomycosis
Single-center study, single blind, comparative with the objective of evaluating the efficacy and safety of an investigational product as an adjunct in the treatment of onychomycosis improvement of 90 days ± 2 days.
100 Clinical Results associated with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
0 Patents (Medical) associated with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
100 Deals associated with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA
100 Translational Medicine associated with MIP Brasil Indústria e Comércio de Produtos Farmacêuticos LTDA